Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Secura Bio Announces Two Duvelisib Presentations on Peripheral T-Cell Lymphoma and Cutaneous T-Cell Lymphoma at the 2026 American Society of Hematology Annual Meeting
-
Corvus Pharmaceuticals Announces Initial Data from Soquelitinib Clinical Trial in Patients with Autoimmune Lymphoproliferative Syndrome (ALPS) will be Presented at the 68ᵗʰ American Society for Hem
-
Umoja Biopharma Announces Oral Presentation of First UB-VV400 In Vivo CAR T Cell Therapy Clinical Data and Four Total Presentations at the 68th ASH Annual Meeting
-
TranscendAP and Carahsoft Partner to Expand Access to AI-Powered AP Automation Across the Public Sector
-
Sophos Helps Organizations Secure the AI-Era Network as Demands on Performance and Protection Grow
-
Jack's Got Your Back: Jackery Kicks Off Black Friday Early with up to $3,230 Off Home Backup Power Solutions
-
Lyell Immunopharma to Present Positive Updated Ronde-Cel Data in More than 80 Patients at ASH 2026 from PiNACLE Pivotal Trial in 3L+ and from Phase 1/2 2L Cohort in Patients with Relapsed/Refractory L
-
Syndax to Host ASH Investor Event in Person and via Webcast on December 14, 2026
-
Phase 1 Data for CITY-FXI, an RNAi Therapeutic Candidate for Thromboembolic Diseases, Selected for Oral Presentation at the 68th ASH Annual Meeting
-
Lakefront Biotherapeutics Announces Poster Presentation at the 2026 American Society of Hematology Meeting
-
Atavistik Bio to Highlight Momentum Across Hematology Pipeline with Harmony-HHT Clinical Trial Update and New Preclinical Data from HHT and JAK2 V617F Programs at ASH 2026
-
New Study Finds Nearly Half of Women Seeking Help for Menstrual Symptoms Say Their Concerns Were Dismissed
-
Geron Corporation to Present Data Highlighting Clinical and Biological Activity of RYTELO® (imetelstat) at ASH 2026
-
SELLAS Life Sciences to Present Positive Phase 2 Data Demonstrating Encouraging Response and Survival Outcomes with SLS009 Combination in High-Risk AML at ASH 2026
-
Caribou Biosciences Announces Presentations at the 2026 American Society of Hematology (ASH) Annual Meeting
-
Descope Unveils Envoy, an Identity-Aware Way For Personal AI Agents to Act on People’s Behalf
-
Darwinium Wins Gold at 2026 AFR BOSS Most Innovative Companies Awards
-
Kamau Therapeutics Announces First Multi-Patient Clinical Data Showing Precise Correction of the Sickle Cell Mutation and Restoration of Adult Hemoglobin
-
Presidio Opens New Engineering Office in Chennai, India, Strengthening Global Technology Delivery Capabilities
-
Castor Maritime Announces that MPC Oceanic Group Has Entered into Agreement to Acquire a 41% Stake in Marlow Navigation
-
PureSky Energy Earns Improved 2025 GRESB Score, Advancing Sustainability Performance and Transparency
-
Kelly® Earns Leader Recognition on Everest Group’s U.S. IT Contingent Talent and Strategic Solutions PEAK Matrix®
-
Automotive CX Research Finds AI Demand Rising as Service Levels Stagnate
-
Sites are Paying the Price for Complexity, and It’s Getting Steeper
-
Peer-Reviewed Scientific Journal Publishes U.S. Clinical Study Reporting Interim Results of 87.7% Accuracy for IR-MED’s PressureSafe™ Technology in Pressure-Injury Assessment
-
Vivakor Highlights Direct Midstream’s New Mexico Operating Agreement as Proposed Acquisition Advances
-
StoneOne Becomes Unified Brand for BearCom and Stone Security
-
Syndax Highlights Acceptance of 19 Revuforj® (revumenib) and Niktimvo™ (axatilimab-csfr) Abstracts, Including 7 for Oral Presentation, at ASH 2026
-
DigiCert Reports Growing ASC X9 Financial PKI Adoption Ahead of DTCC Certificate Deadlines
-
AvePoint Appoints Ali Rohani as Chief Strategy and Customer Officer
-
Cellectar Biosciences to Present Three Posters Highlighting Durable Clinical Activity of Iopofosine I 131 in Waldenström Macroglobulinemia at the American Society of Hematology Annual Meeting and Exp
-
Powering the Play: Verizon Elevates the NFL Gameday Experience Worldwide
-
Beam Therapeutics to Present Updated Clinical Data from BEACON Phase 1/2 Trial of Risto-cel in Sickle Cell Disease in an Oral Presentation at American Society of Hematology (ASH) Annual Meeting
-
ConsumerDirect Sweeps All Eight 2026 Top Workplaces Culture Excellence Awards
-
CSX Executive Vice President and Chief Financial Officer to Address Baird Global Industrial Conference
-
Remitly Global Card Expands Nationwide, Adds Ability to Send and Request Money Across the U.S.
-
Damora Therapeutics to Present New Preclinical Data Highlighting Potentially Best-in-Class Pan-Mutant Activity of DMR-001 in Mutant Calreticulin (mutCALR)-driven Myeloproliferative Neoplasms (MPN) at
-
Cycode Solves Security for Enterprises’ Newest AI Builders: Citizen Developers
-
Solera Announces New FleetLocate Integration with Fleetio to Improve Maintenance Planning
-
Climb Bio to Present New Data for Budoprutug in Immune Thrombocytopenia at the 68th American Society of Hematology Annual Meeting and Exposition
-
Royale Energy to Commence Trading on OTCQB® Venture Market
-
Percona Announces General Availability of Percona Search for MongoDB®
-
Legend Biotech to Showcase CARVYKTI® Leadership and Next-Generation Cell Therapy Innovation at ASH 2026
-
Momentive Software Research Finds Members Want Associations to Lead on Innovation, but Professionals Rank it Near the Bottom
-
Netskope to Report Fiscal Third Quarter 2027 Financial Results on December 2, 2026
-
Truly Hard Seltzer Has Drinks Covered This Friendsgiving with a Custom Potluck Pack
-
Adthena Report Shows ChatGPT Ads Surged to More Than 200,000 Placements Ahead of First AI-Driven Holiday Season
-
Genmab to Present Results from Comprehensive Epcoritamab Development Program Highlighting Potential Across B-Cell Malignancies at the 2026 American Society of Hematology (ASH) Annual Meeting
-
Changes in the Supervisory Council of AB Artea bankas
-
Evaxion will present new target validation data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia at ASH 2026 Meeting
